Longitudinal tracking of axonal loss using diffusion magnetic resonance imaging in multiple sclerosis. Issue 2 (17th March 2022)

• Record Type: Journal Article
• Authors: Boonstra, Frederique M.; Clough, Meaghan; Strik, Myrte; van der Walt, Anneke; Butzkueven, Helmut; White, Owen B.; Law, Meng; Fielding, Joanne; Kolbe, Scott C.
• Is Part Of: Brain communications. Volume 4:Issue 2(2022)
• Publication Date: 2022-03-17
• Subjects: multiple sclerosis -- diffusion magnetic resonance imaging -- axonal degeneration -- longitudinal cohort study; 616
• DOI: 10.1093/braincomms/fcac065
• Languages: English
• ISSNs: 2632-1297

Abstract

Abstract: Axonal loss in the CNS is a key driver of progressive neurological impairments in people with multiple sclerosis. Currently, there are no established methods for tracking axonal loss clinically. This study aimed to determine the sensitivity of longitudinal diffusion MRI-derived fibre-specific measures of axonal loss in people with multiple sclerosis. Fibre measures were derived from diffusion MRI acquired as part of a standard radiological MRI protocol and were compared (i) to establish measures of neuro-axonal degeneration: brain parenchymal fraction and retinal nerve fibre layer thickness and (ii) between different disease stages: clinically isolated syndrome and early/late relapsing–remitting multiple sclerosis. Retrospectively identified data from 59 people with multiple sclerosis (18 clinically isolated syndrome, 22 early and 19 late relapsing–remitting) who underwent diffusion MRI as part of their routine clinical monitoring were collated and analysed. Twenty-six patients had 1-year and 14 patients had a 2-year follow-up. Brain parenchymal fraction was calculated from 3D MRI scans, and fibre-specific measures were calculated from diffusion MRI using multi-tissue constrained spherical deconvolution. At each study visit, patients underwent optical coherence tomography to determine retinal nerve fibre layer thickness, and standard neurological assessment expanded the disability status scale. We found a significant annual fibre-specific neuro-axonal degeneration (mean ± SD = −3.49 ± 3.32%, P < 0.001) that was ∼7 times larger than the annual change of brain parenchymal fraction (−0.53 ± 0.95%, P < 0.001), and more than four times larger than annual retinal nerve fibre layer thinning (−0.75 ± 2.50% P = 0.036). Only fibre-specific measures showed a significant difference in annual degeneration between the disease stages ( P = 0.029). Reduced brain parenchymal fraction, retinal nerve fibre layer thickness and fibre-specific measures were moderately related to higher expanded disability status scale (rho = −0.368, rho = −0.408 and rho = −0.365, respectively). Fibre-specific measures can be measured from data collected within a standard radiological multiple sclerosis study and are substantially more sensitive to longitudinal change compared with brain atrophy and retinal nerve fibre layer thinning. Abstract : This study investigated fibre-specific diffusion MRI in 40 clinically stable people with multiple sclerosis as a marker of progressive neuro-axonal loss. Kolbe et al. report significant changes in fibre-specific measures over only 18 months and significantly greater sensitivity compared with retinal nerve fibre loss and brain atrophy. Graphical Abstract: Graphical Abstract